Publications


A feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma in Australia

An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US

Nativis Research Partner to Present at COGNO Conference in Australia

Non-Thermal Radio Frequency Stimulation Inhibits the Tryptophan Synthase Beta Subunit in the Algae Chlamydomonas reinhardtii

Open Journal of Biophysics Background:  We used the Nativis technology [1] to alter gene expression in the algae Chlamydomonas (short for Chlamydomonas reinhardtii ) [2]. A radio frequency fingerprint is taken from a chemical dissolved in an aqueous solution as described in [1]. The radiofrequency is then transmitted via an antenna array or coil to…

Nativis Research Partner to Present at COGNO Conference in Australia

Non-Thermal Radio Frequency Stimulation of Tubulin Polymerization In Vitro: A Potential Therapy For Cancer Treatment

Open Journal of Biophysics Background:  The use  of radio frequency energy is an established technology for certain oncology therapies.  Direct inputs of radio frequency (RF) energy as thermal energy are applied to ablate tumors or catalyze secondary reactions in adjunct treatments against certain tumor types. Yet, other applications are being developed which take advantage of…

Nativis Research Partner to Present at COGNO Conference in Australia

A Feasibility Study Of The Nativis Voyager System In Patients With Recurrent Glioblastoma Multiforme (GBM): Interim Results Of First-In-Human Study

2017 ASCO Annual Meeting Abstract Background:  In this prospective, multi-center trial, patients with GBM, following recurrence after receiving standard-of-care chemotherapy and/or radiotherapy were considered for the study. Patients were treated with Voyager alone or with Voyager plus concurrent chemotherapy or Avastin at the discretion of the investigator. Safety was assessed by incidence of any adverse…